Advances in colposcopy: new technologies to challenge current practice.

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Conventional colposcopy exhibits limited sensitivity in detecting precancerous cervical abnormalities.
• Cervical screening programs are evolving with HPV vaccination and HPV-based screening.
• These shifts are projected to decrease high-grade cervical intraepithelial neoplasia (CIN) and cervical cancer incidence.

Purpose of the Study:

• To review emerging technologies for assessing precancerous cervical abnormalities.
• To explore alternatives or adjuncts to conventional colposcopy.
• To address the challenges posed by changing screening paradigms to colposcopic assessment.

Main Methods:

• Literature review of current and emerging diagnostic technologies for cervical abnormalities.
• Analysis of the impact of HPV vaccination and HPV-based screening on colposcopy referrals and diagnostic performance.
• Discussion of technological advancements in colposcopic assessment.

Main Results:

• HPV vaccination and HPV-based screening are expected to lower the prevalence of high-grade CIN.
• Increased colposcopic referrals are anticipated due to HPV-based screening.
• The diagnostic performance of conventional colposcopy may be further challenged by these changes.

Conclusions:

• New technologies are crucial to enhance the assessment of precancerous cervical abnormalities.
• Integrating advanced technologies may improve diagnostic accuracy in the evolving landscape of cervical screening.
• Future cervical screening strategies will likely rely on a combination of HPV testing and improved colposcopic assessment tools.